Search results for aurka

306 hits were found for aurka

# Family MCID Name MIFTS Score
1
P CLR023 Colorectal Cancer 100 42.657
2
P BRS047 Breast Cancer 98 27.212
3
P GST053 Gastric Cancer 83 25.106
4
P BLD134 Bladder Cancer 79 22.354
5
P LNG032 Lung Cancer 98 22.225
6
P HPT023 Hepatocellular Carcinoma 96 20.436
7
P OVR042 Ovarian Cancer 88 20.351
8
END057 Endometrial Cancer 72 19.894
9
P PNC035 Pancreatic Cancer 86 19.223
10
P NRB001 Neuroblastoma 66 18.983
11
P MLN008 Melanoma 76 18.916
12
P PRS040 Prostate Cancer 95 18.538
13
LRY018 Laryngeal Squamous Cell Carcinoma 44 15.785
14
CLR109 Colorectal Adenocarcinoma 50 15.188
15
MYL069 Myeloma, Multiple 77 15.001
16
CRV035 Cervical Cancer 73 14.786
17
ESP021 Esophageal Cancer 83 14.496
18
P MDL005 Medulloblastoma 75 13.414
19
PLS009 Plasma Cell Neoplasm 64 11.691
20
P RHB003 Rhabdomyosarcoma 66 11.046
21
P LYN001 Lynch Syndrome 76 11.046
22
ATY005 Atypical Teratoid Rhabdoid Tumor 69 10.733
23
c PRM031 Primary Autosomal Recessive Microcephaly 55 9.384
24
SPP011 Suppression of Tumorigenicity 12 61 9.108
25
TTR011 Tetraploidy 43 7.589
26
SQM006 Squamous Cell Carcinoma 60 7.404
27
UTR033 Uterine Corpus Cancer 44 7.055
28
DNH001 Donohue Syndrome 61 7.055
29
ADL042 Adult Malignant Schwannoma 33 7.055
30
CHL033 Childhood Malignant Schwannoma 33 7.055
31
PRS017 Prostate Neuroendocrine Neoplasm 24 7.055
32
END085 Endometrial Serous Adenocarcinoma 43 7.055
33
P LNG064 Lung Cancer Susceptibility 3 70 6.728
34
P ADN016 Adenocarcinoma 63 5.843
35
RNL114 Renal Cell Carcinoma, Nonpapillary 80 5.157
36
GLB002 Glioblastoma 67 5.131
37
c LKM061 Leukemia, Acute Myeloid 83 4.699
38
GST040 Gastric Adenocarcinoma 67 4.699
39
GLM045 Glioma 63 4.505
40
c SML038 Small Cell Cancer of the Lung 69 4.486
41
ORL015 Oral Squamous Cell Carcinoma 43 4.486
42
OVR094 Ovarian Epithelial Cancer 39 4.018
43
GLL048 Glial Tumor 52 3.831
44
CLR030 Clear Cell Renal Cell Carcinoma 54 3.780
45
P MYL006 Myeloid Leukemia 61 3.731
46
OST159 Osteogenic Sarcoma 66 3.628
47
ADN018 Adenoma 59 3.613
48
ORL011 Oral Cancer 60 3.613
49
CLR108 Colorectal Adenoma 64 3.497
50
SKN019 Skin Melanoma 71 3.347
51
BRS099 Breast Ductal Carcinoma 61 3.214
52
PLY100 Polyploidy 36 3.201
53
END041 Endometrial Adenocarcinoma 64 3.181
54
P GLM040 Glioma Susceptibility 1 71 3.163
55
c LKM063 Leukemia, Chronic Myeloid 71 3.145
56
OST012 Osteoarthritis 77 2.906
57
MYL005 Myelofibrosis 71 2.830
58
MYL031 Myeloproliferative Neoplasm 66 2.776
59
LNG039 Lung Squamous Cell Carcinoma 57 2.655
60
END002 Endometrioid Ovary Carcinoma 52 2.638
61
P MCR010 Microcephaly 60 2.638
62
HYP266 Hypoxia 57 2.638
63
P SML001 Small Cell Carcinoma 52 2.565
64
P LPS002 Liposarcoma 64 2.565
65
GST019 Gastrointestinal Stromal Tumor 78 2.561
66
P CRB210 Cerebrofacial Arteriovenous Metameric Syndrome 27 2.490
67
MLG169 Malignant Astrocytoma 57 2.490
68
SFT003 Soft Tissue Sarcoma 57 2.490
69
HPT022 Hepatoblastoma 54 2.328
70
P LKM002 Leukemia 67 2.328
71
P CHN012 Chondrosarcoma 57 2.242
72
PNC041 Pancreatic Ductal Adenocarcinoma 51 2.202
73
MYL009 Myelodysplastic Syndrome 67 2.150
74
ATH013 Atherosclerosis Susceptibility 63 2.053
75
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 59 2.053
76
GST103 Gastric Cancer, Hereditary Diffuse 68 2.020
77
P OVR082 Overgrowth Syndrome 49 1.973
78
c SPR009 Sporadic Breast Cancer 42 1.973
79
SQM013 Squamous Cell Carcinoma, Head and Neck 73 1.948
80
ADR016 Adrenal Cortical Carcinoma 62 1.948
81
ADR054 Adrenocortical Carcinoma, Hereditary 47 1.948
82
ADR004 Adrenal Cortical Adenocarcinoma 38 1.948
83
MCR013 Microphthalmia 60 1.948
84
SPL018 Splenomegaly 49 1.948
85
c PLY162 Polyposis Syndrome, Hereditary Mixed, 1 60 1.904
86
c CLR087 Colorectal Cancer 12 34 1.904
87
SML009 Small Intestine Adenocarcinoma 57 1.904
88
CHL065 Cholangiocarcinoma 58 1.850
89
SPN035 Spindle Cell Sarcoma 54 1.850
90
SRC014 Sarcoma 65 1.850
91
INT079 Intrahepatic Cholangiocarcinoma 51 1.850
92
PRS129 Prostatic Hyperplasia, Benign 49 1.834
93
OVR105 Ovarian Serous Carcinoma 37 1.834
94
PRS021 Prostatic Adenoma 43 1.834
95
P HPT021 Hepatitis 69 1.834
96
PRS045 Prostatic Hypertrophy 53 1.834
97
c HPT016 Hepatitis B 62 1.834
98
CLN015 Colon Adenocarcinoma 65 1.781
99
THY029 Thyroid Carcinoma 51 1.771
100
GST092 Gastroesophageal Reflux 61 1.708
101
P ESP024 Esophagitis 60 1.708
102
P RTN024 Retinoblastoma 73 1.689
103
P INF032 Infertility 57 1.689
104
P INS002 in Situ Carcinoma 53 1.689
105
P NRF002 Neurofibromatosis 57 1.689
106
SML031 Small Cell Carcinoma of the Bladder 46 1.649
107
ADN011 Adenoid Cystic Carcinoma 68 1.649
108
P PLY014 Polycystic Kidney Disease 69 1.602
109
P MLN007 Male Infertility 56 1.602
110
MSC157 Muscular Dystrophy, Duchenne Type 79 1.565
111
P MSC005 Muscular Dystrophy 67 1.565
112
c PRM212 Primary Microcephaly 40 1.565
113
P OVR106 Ovarian Clear Cell Carcinoma 44 1.511
114
ACT250 Acute Megakaryocytic Leukemia 60 1.511
115
PRP036 Peripheral T-Cell Lymphoma 53 1.413
116
c ATS347 Autosomal Dominant Polycystic Kidney Disease 66 1.413
117
P BCL017 B-Cell Lymphoma 59 1.413
118
BRR002 Barrett's Adenocarcinoma 37 1.413
119
MLG077 Malignant Peripheral Nerve Sheath Tumor 54 1.413
120
c RTN041 Retinitis Pigmentosa 11 42 1.395
121
P EST001 Estrogen-Receptor Positive Breast Cancer 49 1.395
122
NRN001 Neuroendocrine Carcinoma 47 1.395
123
ACT200 Acute Monoblastic Leukemia 41 1.395
124
P TMR010 Tumor Predisposition Syndrome 67 1.347
125
ADN089 Adenosquamous Lung Carcinoma 49 1.347
126
BRN015 Bronchiolo-Alveolar Adenocarcinoma 55 1.347
127
P LYM118 Lymphoma 67 1.308
128
HLC007 Helicobacter Pylori Infection 67 1.308
129
P KDN018 Kidney Disease 72 1.308
130
CRV038 Cervical Squamous Cell Carcinoma 58 1.308
131
P GRF003 Graft-Versus-Host Disease 71 1.308
132
P NTR004 Neutropenia 63 1.308
133
TST014 Testicular Cancer 52 1.308
134
SVR004 Severe Combined Immunodeficiency 72 1.308
135
48X005 48,xyyy 39 1.308
136
P OLG002 Oligodendroglioma 66 1.207
137
MRK001 Merkel Cell Carcinoma 64 1.207
138
CLT003 Colitis 63 1.194
139
c NRF024 Neurofibromatosis, Type I 72 1.194
140
c ACT073 Acute Leukemia 58 1.194
141
P ATR005 Atrophic Gastritis 50 1.194
142
ULC004 Ulcerative Colitis 74 1.194
143
P GST044 Gastritis 55 1.194
144
RHB001 Rhabdoid Cancer 68 1.194
145
P LMY004 Leiomyosarcoma 62 1.194
146
c ACT135 Acute Graft Versus Host Disease 51 1.194
147
c LKM070 Leukemia, Acute Monocytic 56 1.174
148
UTR056 Uterine Corpus Endometrial Carcinoma 27 1.174
149
P NSP012 Nasopharyngeal Carcinoma 61 1.068
150
MNT001 Mantle Cell Lymphoma 67 1.068
151
P BLY001 B-Lymphoblastic Leukemia/lymphoma 52 1.068
152
P LKM062 Leukemia, Acute Lymphoblastic 69 1.068
153
EWN003 Ewing Sarcoma 70 1.068
154
c HPT073 Hepatitis C Virus 71 1.068
155
DCT002 Ductal Carcinoma in Situ 58 1.068
156
P PSR002 Psoriasis 63 1.068
157
c HPT001 Hepatitis C 62 1.068
158
PST011 Pustulosis of Palm and Sole 52 1.068
159
MLG079 Malignant Pleural Mesothelioma 42 1.068
160
CMB007 Combined Immunodeficiency 57 1.068
161
ANG020 Angiosarcoma 64 1.068
162
MCS002 Mucositis 56 1.068
163
P BNG032 Benign Mesothelioma 53 1.068
164
EMB007 Embryonal Sarcoma 40 1.068
165
HPT070 Hepatosplenic T-Cell Lymphoma 36 0.964
166
LYM133 Lymphoma, Hodgkin, Classic 74 0.925
167
CLP005 Ciliopathy 41 0.925
168
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 45 0.925
169
LWG006 Low Grade Glioma 41 0.925
170
LYM143 Lymphoma, Non-Hodgkin, Familial 75 0.925
171
SMT018 Smith-Mccort Dysplasia 2 34 0.925
172
MLC004 Mulchandani-Bhoj-Conlin Syndrome 51 0.925
173
P THR014 Thrombocytopenia 66 0.925
174
SKN016 Skin Disease 63 0.925
175
PNC129 Pancreatic Adenocarcinoma 65 0.925
176
c PRC016 Pre-Eclampsia 65 0.925
177
P TCD001 Tic Disorder 49 0.925
178
NRF007 Neurofibroma 64 0.925
179
P AST005 Asthma 76 0.755
180
c SYS001 Systemic Lupus Erythematosus 87 0.755
181
THY121 Thyroid Gland Anaplastic Carcinoma 67 0.755
182
CNN010 Connective Tissue Benign Neoplasm 44 0.755
183
ART074 Aortic Dissection 53 0.755
184
BRN032 Brain Glioma 45 0.755
185
GLC053 Glucocorticoid Deficiency 3 20 0.755
186
SCH038 Schopf-Schulz-Passarge Syndrome 51 0.755
187
P LPS004 Lupus Erythematosus 61 0.755
188
CRV002 Cervix Uteri Carcinoma in Situ 47 0.755
189
P SKN015 Skin Carcinoma 71 0.755
190
P EPT012 Epithelioid Sarcoma 41 0.755
191
HLX001 Helix Syndrome 48 0.755
192
P END044 Endometriosis 62 0.755
193
c INF023 Inflammatory Breast Carcinoma 49 0.755
194
FBR086 Fibrolamellar Carcinoma 59 0.755
195
NRL005 Neurilemmoma 60 0.755
196
OCL022 Ocular Melanoma 52 0.755
197
PLM033 Pulmonary Embolism 58 0.755
198
CRV045 Cervical Intraepithelial Neoplasia 39 0.755
199
P RTH006 Rothmund-Thomson Syndrome, Type 2 67 0.673
200
RMB001 Rombo Syndrome 30 0.673
201
PLM026 Pilomatrixoma 57 0.673
202
VNH007 Von Hippel-Lindau Syndrome 73 0.673
203
c GLM047 Glioma Susceptibility 3 33 0.673
204
LNG111 Lung Non-Squamous Non-Small Cell Carcinoma 56 0.673
205
LMN016 Luminal Breast Carcinoma B 28 0.673
206
P LMN015 Luminal Breast Carcinoma a 35 0.673
207
c PRS097 Prostate Cancer, Hereditary, 1 39 0.673
208
P TRC095 Trichoepithelioma, Multiple Familial, 1 32 0.673
209
c MSM022 Mismatch Repair Cancer Syndrome 1 70 0.673
210
c BSL024 Basal Cell Carcinoma 1 55 0.673
211
BSL044 Basal Cell Carcinoma, Infundibulocystic 35 0.673
212
c GLM025 Glioma Susceptibility 2 30 0.673
213
c GLM043 Glioma Susceptibility 9 30 0.673
214
c BSL034 Basal Cell Carcinoma 7 26 0.673
215
c PRS070 Prostate Cancer, Hereditary, 12 22 0.673
216
c PRS071 Prostate Cancer, Hereditary, 13 25 0.673
217
c PRS117 Prostate Cancer, Hereditary, 11 24 0.673
218
PLM173 Palmoplantar Hyperkeratosis with Squamous Cell Carcinoma of Skin and 46,xx Sex Reversal 34 0.673
219
c ALB010 Albinism, Oculocutaneous, Type Ib 52 0.673
220
c PRS114 Prostate Cancer, Hereditary, 2 33 0.673
221
MNN043 Meningioma, Familial 79 0.673
222
MLT165 Multilocular Cystic Renal Neoplasm of Low Malignant Potential 28 0.673
223
MLT003 Multilocular Clear Cell Renal Cell Carcinoma 32 0.673
224
CYS004 Cystic Basal Cell Carcinoma 36 0.673
225
SRC003 Sarcomatoid Basal Cell Carcinoma 28 0.673
226
P LNG021 Lung Occult Small Cell Carcinoma 20 0.673
227
END018 Endometrium Carcinoma in Situ 29 0.673
228
NDL009 Nodular Basal Cell Carcinoma 40 0.673
229
MTT001 Metatypical Basal Cell Carcinoma 32 0.673
230
PGM002 Pigmented Basal Cell Carcinoma 31 0.673
231
MCR016 Micronodular Basal Cell Carcinoma 34 0.673
232
INF027 Infiltrative Basal Cell Carcinoma 32 0.673
233
LNG019 Lung Combined Type Small Cell Carcinoma 32 0.673
234
SKN022 Skin Squamous Cell Carcinoma 54 0.673
235
ANL013 Anal Margin Basal Cell Carcinoma 18 0.673
236
SBC013 Sebaceous Basal Cell Carcinoma 13 0.673
237
ADM002 Adamantinoid Basal Cell Epithelioma 20 0.673
238
CLR015 Clear Cell Basal Cell Carcinoma 39 0.673
239
ADN015 Adenoid Basal Cell Carcinoma 31 0.673
240
P LNG035 Lung Large Cell Carcinoma 54 0.673
241
SGN001 Signet Ring Basal Cell Carcinoma 32 0.673
242
VLV032 Vulva Cancer 60 0.673
243
c BSL007 Basal Cell Carcinoma 68 0.673
244
PPL004 Papillary Squamous Carcinoma 39 0.673
245
PNS010 Penis Squamous Cell Carcinoma 45 0.673
246
LNG006 Lung Occult Large Cell Carcinoma 14 0.673
247
PNS005 Penis Mixed Squamous Cell Carcinoma 12 0.673
248
PSD011 Pseudovascular Skin Squamous Cell Carcinoma 16 0.673
249
PRS015 Prostate Signet Ring Cell Adenocarcinoma 25 0.673
250
VGN017 Vaginal Cancer 59 0.673
251
9Q2001 9q22.3 Microdeletion 24 0.673
252
RCS008 Recessive Dystrophic Epidermolysis Bullosa-Generalized Other 30 0.673
253
INF057 Inflammatory Linear Verrucous Epidermal Nevus 33 0.673
254
LNR004 Linear Porokeratosis 33 0.673
255
P RTT002 Rett Syndrome 79 0.534
256
SRC027 Sarcoma, Synovial 58 0.534
257
P SPR119 Spermatogenic Failure, X-Linked, 1 36 0.534
258
BRK010 Burkitt Lymphoma 66 0.534
259
CYS001 Cystic Fibrosis 78 0.534
260
c FNC027 Fanconi Anemia, Complementation Group a 81 0.534
261
c FNC029 Fanconi Anemia, Complementation Group I 56 0.534
262
MTR088 Mature T-Cell and Nk-Cell Lymphoma 42 0.534
263
P ANP001 Anaplastic Large Cell Lymphoma 61 0.534
264
LYM012 Lymphoplasmacytic Lymphoma 50 0.534
265
P INF037 Inflammatory Bowel Disease 53 0.534
266
ACT098 Acute Erythroid Leukemia 55 0.534
267
DDF001 Dedifferentiated Liposarcoma 49 0.534
268
DFF039 Diffuse Midline Glioma, H3 K27m-Mutant 47 0.534
269
WLD007 Waldenstroem's Macroglobulinemia 63 0.534
270
c FNC042 Fanconi Anemia, Complementation Group D2 54 0.534
271
KPS004 Kaposi Sarcoma 77 0.534
272
EST007 Estrogen Resistance 41 0.534
273
DWN001 Down Syndrome 70 0.534
274
P HNT016 Huntington Disease 73 0.534
275
THY111 Thyroid Carcinoma, Familial Medullary 67 0.534
276
PLM129 Pulmonary Disease, Chronic Obstructive 74 0.534
277
RPD005 Rapidly Involuting Congenital Hemangioma 46 0.534
278
MLG118 Malignancy Diagnosed During Pregnancy 16 0.534
279
MCR004 Macroglobulinemia 49 0.534
280
WLL039 Well-Differentiated Liposarcoma 40 0.534
281
P NRP001 Neuropathy 60 0.534
282
APP009 Appendix Adenocarcinoma 45 0.534
283
47X002 47,xyy 48 0.534
284
MCN001 Mucinous Adenocarcinoma 49 0.534
285
PLM030 Pleomorphic Rhabdomyosarcoma 40 0.534
286
THY022 Thymic Carcinoma 57 0.534
287
TRT001 Teratocarcinoma 42 0.534
288
THY125 Thyroid Gland Medullary Carcinoma 48 0.534
289
LNG099 Lung Disease 62 0.534
290
P CHR071 Charcot-Marie-Tooth Disease 64 0.534
291
BRN028 Brain Cancer 74 0.534
292
PPL022 Papilloma 53 0.534
293
SQM002 Squamous Cell Papilloma 46 0.534
294
TTH006 Tooth Disease 51 0.534
295
ACR014 Acral Lentiginous Melanoma 52 0.534
296
THY020 Thyroid Hyalinizing Trabecular Adenoma 20 0.534
297
P INT068 Intestinal Disease 53 0.534
298
P PRP019 Peripheral Nervous System Disease 58 0.534
299
PRS008 Prostate Small Cell Carcinoma 25 0.534
300
EMB004 Embryonal Carcinoma 56 0.534
301
P KDN017 Kidney Cancer 61 0.534
302
PTT037 Pituitary Tumors 44 0.534
303
CHR178 Chromosomal Triplication 34 0.534
304
RTR012 Retroperitoneal Liposarcoma 23 0.534
306
c WLM018 Wilms Tumor 5 53 0.430
Content
Loading form....